Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| USNA | USANA HEALTH SCIENCES INC | 2025-12-02 08:13:33 | 20.3 | 0.68 | 3.45 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| USNA | 0000896264 | USANA HEALTH SCIENCES INC | US90328M1071 | 549300YTURXE814MAH96 | 870500306 | NYSE | 2833 | Medicinal Chemicals & Botanical Products | 0103 | UT | 3838 WEST PARKWAY BLVD. | SALT LAKE CITY | UT | 84120-6336 | UNITED STATES | US | 8019547100 | 3838 WEST PARKWAY BLVD., SALT LAKE CITY, UT, 84120-6336 | 3838 WEST PARKWAY BLVD., SALT LAKE CITY, UT, 84120-6336 | USANA INC | — | 1992 | Jim Brown | 1,978 | http://usana.com | 499,000,000 | 18,272,000 | 18,280,857 | Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors. | 2025-11-27 18:10:45 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2023 | 499,000,000 | -927,392,900 | -65.0167 | 18,904,526 | -389,806 | -2.0203 |
| 2022 | 1,426,392,900 | 609,328,766 | 74.5754 | 19,294,332 | -1,557,936 | -7.4713 |
| 2020 | 817,064,134 | -222,714,599 | -21.4194 | 20,852,268 | -696,274 | -3.2312 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Walter Noot | Chief Operating Officer | 2024 | 550,300 | 0 | — | 40,557 | 22,075 | 1,438,431 |
| Brent Neidig | Chief Commercial Officer | 2024 | 500,245 | 0 | — | 36,868 | 12,075 | 1,299,581 |
| Jim H. Brown | President, Chief Executive Officer | 2024 | 800,000 | 0 | — | 117,908 | 44,181 | 3,362,107 |
| G. Douglas Hekking | Chief Financial Officer | 2024 | 553,829 | 0 | — | 40,817 | 15,520 | 1,440,953 |
| Joshua Foukas | Chief Legal Officer, General Counsel | 2024 | 487,630 | 0 | — | 35,938 | 13,289 | 1,268,334 |
| Fiscal Year | Employee Count |
|---|---|
| 2024 | 1,700 |
| 2023 | 1,800 |
| 2022 | 1,900 |
| Fiscal Year | 2023 | 2022 | 2020 |
|---|---|---|---|
| Revenue | 854,503,000 | 998,601,000 | 1,134,644,000 |
| Cost Of Revenue | 161,212,000 | 193,890,000 | 209,111,000 |
| Gross Profit | 693,291,000 | 804,711,000 | 925,533,000 |
| Research And Development Expenses | 11,571,000 | 11,563,000 | 10,633,000 |
| General And Administrative Expenses | 263,268,000 | 262,304,000 | 261,186,000 |
| Operating Expenses | 626,967,000 | 697,097,000 | 749,042,000 |
| Operating Income | 66,324,000 | 107,614,000 | 176,491,000 |
| Net Income | 42,030,000 | 69,350,000 | 124,664,000 |
| Earnings Per Share Basic | 2.2 | 3.6 | 5.89 |
| Earnings Per Share Diluted | 2.19 | 3.59 | 5.86 |
| Weighted Average Shares Outstanding Basic | 19,103,000 | 19,254,000 | 21,156,000 |
| Weighted Average Shares Outstanding Diluted | 19,162,000 | 19,310,000 | 21,256,000 |
| Fiscal Year | 2023 | 2022 | 2020 |
|---|---|---|---|
| Cash And Cash Equivalents | 181,768,000 | 288,420,000 | 311,917,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | — | — | — |
| Inventories | 69,735,000 | 67,089,000 | 90,224,000 |
| Non Trade Receivables | 804,000 | 2,030,000 | 1,168,000 |
| Other Assets Current | 4,808,000 | 7,121,000 | 4,966,000 |
| Total Assets Current | 279,187,000 | 384,382,000 | 425,286,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 94,565,000 | 97,773,000 | 100,445,000 |
| Other Assets Non Current | 58,806,000 | 54,795,000 | 62,353,000 |
| Total Assets Non Current | 137,841,000 | 197,267,000 | 210,961,000 |
| Total Assets | 748,193,000 | 596,549,000 | 640,887,000 |
| Accounts Payable | 11,984,000 | 11,049,000 | 18,195,000 |
| Deferred Revenue | 12,050,000 | 20,875,000 | 15,952,000 |
| Short Term Debt | 23,000,000 | — | — |
| Other Liabilities Current | 104,641,000 | 132,784,000 | 149,878,000 |
| Total Liabilities Current | 139,625,000 | 143,833,000 | 168,073,000 |
| Long Term Debt | — | — | — |
| Other Liabilities Non Current | 18,163,000 | 14,173,000 | 19,155,000 |
| Total Liabilities Non Current | 22,236,000 | — | — |
| Total Liabilities | 161,861,000 | — | — |
| Common Stock | 19,000 | 19,000 | 21,000 |
| Retained Earnings | 478,944,000 | 391,636,000 | 382,794,000 |
| Accumulated Other Comprehensive Income | -22,670,000 | -12,787,000 | -3,625,000 |
| Total Shareholders Equity | 532,109,000 | 434,472,000 | 441,650,000 |
| Fiscal Year | 2023 | 2022 | 2020 |
|---|---|---|---|
| Depreciation And Amortization | 14,539,000 | 13,393,000 | 13,747,000 |
| Share Based Compensation Expense | 14,558,000 | 13,331,000 | 14,394,000 |
| Other Non Cash Income Expense | -1,000 | -141,000 | -191,000 |
| Change In Accounts Receivable | — | — | — |
| Change In Inventories | 2,118,000 | -21,879,000 | 16,784,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | -1,269,000 | -2,656,000 | 6,076,000 |
| Change In Other Liabilities | -6,745,000 | -9,066,000 | 16,456,000 |
| Cash From Operating Activities | 60,992,000 | 103,902,000 | 160,401,000 |
| Purchases Of Marketable Securities | — | — | — |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 10,073,000 | 10,400,000 | 15,094,000 |
| Acquisition Of Business | 203,336,000 | 6,532,000 | — |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -213,090,000 | -12,370,000 | -33,961,000 |
| Tax Withholding For Share Based Compensation | 3,223,000 | 4,706,000 | 2,367,000 |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | 9,444,000 | 25,382,000 | 57,029,000 |
| Issuance Of Long Term Debt | — | — | — |
| Repayment Of Long Term Debt | 1,467,000 | 11,000,000 | 60,000,000 |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | 9,553,000 | -30,088,000 | -59,442,000 |
| Change In Cash | -148,738,000 | 47,667,000 | 78,249,000 |
| Cash At End Of Period | 181,768,000 | 288,420,000 | 311,917,000 |
| Income Taxes Paid | 40,470,000 | 45,863,000 | 53,015,000 |
| Interest Paid | 76,000 | 49,000 | 711,000 |
| Fiscal Year | 2023 | 2022 | 2020 |
|---|---|---|---|
| Earnings Per Share | 2.2 | 3.6 | 5.89 |
| Price To Earnings Ratio | 16.2227 | 14.7778 | 13.09 |
| Earnings Growth Rate | -38.8889 | -38.8795 | 32.6577 |
| Price Earnings To Growth Ratio | -0.4172 | -0.3801 | 0.4008 |
| Book Value Per Share | 30.6932 | 23.5128 | 22.3489 |
| Price To Book Ratio | 1.1628 | 2.2626 | 3.4498 |
| Ebitda | 97,320,000 | 128,798,000 | 191,933,000 |
| Enterprise Value | — | — | — |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | — | — | — |
| Capital Expenditures | 11,331,000 | 10,721,000 | 18,959,000 |
| Free Cash Flow | 49,661,000 | 93,181,000 | 141,442,000 |
| Return On Equity | 0.079 | 0.1596 | 0.2823 |
| One Year Beta | 0.9685 | 0.5276 | 0.9406 |
| Three Year Beta | 0.6535 | 0.779 | 0.8553 |
| Five Year Beta | 0.7911 | 0.753 | 0.8928 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Winssinger Frederic J | Director | 2025-11-10 | 2,000 | D | 5,986 |
| FULLER GILBERT A | Director | 2025-11-03 | 1,057 | D | 0 |
| Fleming John Turman | Director | 2025-10-31 | 1,750 | D | 4,565 |
| WOOD TIMOTHY E | Director | 2025-10-23 | 1,057 | A | 9,292 |
| WOOD TIMOTHY E | Director | 2025-10-23 | 265 | D | 9,027 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| JPMORGAN CHASE & CO | 2025-09-30 | 259,080 | 9,404 | 27.55 |
| Sunbelt Securities, Inc. | 2025-09-30 | 358 | 13 | 27.5385 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2025-09-30 | 7,300,006 | 264,973 | 27.55 |
| Arax Advisory Partners | 2025-09-30 | 49,894 | 1,811 | 27.5505 |
| AQR CAPITAL MANAGEMENT LLC | 2025-09-30 | 2,089,034 | 75,827 | 27.55 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| RYDEX SERIES FUNDS | 2025-09-30 | Class C | RYCMX | 16 | 440.8 | 0.0066 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class A | RYAKX | 16 | 440.8 | 0.0066 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class H | RYMKX | 16 | 440.8 | 0.0066 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class H | RYRHX | 26 | 716.3 | 0.0058 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class C | RYROX | 26 | 716.3 | 0.0058 |